A recent poll found that about 15.5 million Americans have used injectable diabetes medicines like Ozempic and Wegovy to lose ...

In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...

What’s happening in California, the impact of Ozempic, a look at some franchisee valuations, Greg Flynn’s thoughts on ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

A research team in China has held atoms in a state of quantum superposition for 23 minutes, suggesting tantalizing new ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...